Russia plans to begin mass trials of its second coronavirus vaccine, EpiVacCorona, on people aged over 18 on Monday, the RIA news agency cited the consumer health watchdog Rospotrebnadzor as…

Read more »

The post Russia Begins Mass Trials of Second Coronavirus Vaccine appeared first on Hamodia.

In related news:

  1. China: All Coronavirus Patients in Wuhan Have Now Been Discharged
  2. Sun Draws Many Out in U.S., Europe; Russia virus Numbers Grow
  3. U.S. Steers Clear as Global COVID-19 Pledging Conference Begins
  4. Australia Closes State Border for First Time in 100 Years After COVID-19 Spike
  5. WHO Reports Record Daily Increase in Global Coronavirus Cases for Second Day in a Row